Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 60.89 USD 2.94% Market Closed
Market Cap: 7.6B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

GH Price Targets Summary
Guardant Health Inc

Wall Street analysts forecast GH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GH is 61.27 USD with a low forecast of 20.2 USD and a high forecast of 73.5 USD.

GH Lowest Forecast
Wall Street Target
20.2 USD
67% Downside
GH Average Forecast
Wall Street Target
61.27 USD
1% Upside
GH Highest Forecast
Wall Street Target
73.5 USD
21% Upside
Lowest
Price Target
20.2 USD
67% Downside
Average
Price Target
61.27 USD
1% Upside
Highest
Price Target
73.5 USD
21% Upside
Guardant Health Inc Competitors:
Price Targets
QC7
Q & M Dental Group (Singapore) Ltd
6% Upside
H
AIDX
Healwell Al Inc
144% Upside
PRDA
Prodia Widyahusada Tbk PT
5% Upside
A
AND
Andlauer Healthcare Group Inc
6% Upside
QC7
Q & M Dental Group (Singapore) Ltd
6% Upside
H
AIDX
Healwell Al Inc
144% Upside
PRDA
Prodia Widyahusada Tbk PT
5% Upside
A
AND
Andlauer Healthcare Group Inc
6% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
38% Upside
MD
MEDNAX Inc
4% Upside
KRSNAA
Krsnaa Diagnostics Ltd
35% Upside
CHE
Chemed Corp
31% Upside

Revenue
Forecast

Revenue Estimate
Guardant Health Inc

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 23%.

47%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

See Also

Summary
GH intrinsic value, competitors valuation, and company profile.
DCF Valuation
GH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GH stock valuation using valuation multiples.
Wall Street Estimates
GH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GH's stock price target?
Price Target
61.27 USD

According to Wall Street analysts, the average 1-year price target for GH is 61.27 USD with a low forecast of 20.2 USD and a high forecast of 73.5 USD.

What is Guardant Health Inc's Revenue forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 284,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.